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Circulating Lymphocyte Subsets, Natural Killer Cell Cytotoxicity, and 
Components of Hypothalamic-Pituitary-Adrenal Axis in Croatian War 
Veterans with Posttraumatic Stress Disorder: Cross-Sectional Study
Aim To determine peripheral blood lymphocyte subsets – T cells, helper 
T cells, cytotoxic T cells, B cells, and natural killer cells, natural killer 
cell cytotoxicity, serum cortisol concentration, and lymphocyte glucocor-
ticoid receptor expression in Croatian combat veterans diagnosed with 
chronic posttraumatic stress disorder (PTSD); and to examine the rela-
tionship between the assessed parameters and the time passed since the 
traumatic experience.
Methods Well-characterized group of 38 PTSD patients was compared 
to a group of 24 healthy civilians. Simultaneous determination of lym-
phocyte subsets and the expression of intracellular glucocorticoid recep-
tor was performed using three-color flow cytometry. Natural killer cell 
cytotoxicity was measured by 51Cr-release assay and the serum cortisol 
concentration was determined by radioimmunoassay.
Results We found higher lymphocyte counts in PTSD patients than in 
healthy controls (2294.7 ± 678.0/μL vs 1817.2 ± 637.0/μL, P = 0.007) 
and a positive correlation between lymphocyte glucocorticoid recep-
tor expression and the number of years that passed from the traumatic 
experience (rs = 0.43, P = 0.008). Lymphocyte glucocorticoid receptor 
expression positively correlated with serum cortisol concentration both 
in PTSD patients (r = 0.46, P = 0.006) and healthy controls (r = 0.46, 
P = 0.035).
Conclusion This study confirmed that the immune system was affected 
in the course of chronic PTSD. Our findings also indicated that the hy-
pothalamic-pituitary-adrenal axis profile in PTSD was associated with 
the duration of the disorder. Due to the lack of power, greater sample 
sizes are needed to confirm the results of this study.
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Prolonged or frequently repeated stress response 
during symptomatic episodes in chronic post-
traumatic stress disorder (PTSD) can result in 
neuroendocrine and immune alterations, pos-
ing serious threat to mental and physical health 
(1,2). Evidence suggests that PTSD is related to 
increased medical morbidity, particularly from 
cardiovascular and autoimmune diseases (3). 
With controversial findings when neurobiol-
ogy of PTSD is concerned, the patophysiologi-
cal mechanisms underlying increased suscepti-
bility to disease are not clear (4,5). However, it 
has been implicated that the sympathetic-adre-
nal-medullary (SAM) and the hypothalamic-pi-
tuitary-adrenal axes are the key mediators in this 
process (6,7).
The immune system interacts with the hy-
pothalamic-pituitary-adrenal axis in a bidirec-
tional fashion to maintain homeostasis. Being 
the primary effector of the stress response, corti-
sol modifies the complex cytokine network and, 
consequently, leukocyte function and recircula-
tion (8). These effects are achieved through its in-
teraction with the specific intracellular glucocor-
ticoid receptors (9).
Studies of the leukocyte recirculation (10,11), 
immune cells function (12), and hypothalamic-
pituitary-adrenal axis activity (5) in PTSD yield-
ed controversial results. Overall findings sup-
port the hypothesis that immune activation in 
PTSD may be associated with Th2 cytokine shift 
and alterations in the proinflammatory cytokine 
system (4). Besides, it is believed that PTSD is 
linked with low plasma cortisol levels and high-
er glucocorticoid receptor expression, suggesting 
enhanced feedback sensitivity to cortisol (13). 
In contrast to these findings, Gotovac et al (14) 
showed that Croatian combat veterans with 
PTSD, approximately 6 years after traumatic 
event, had lower expression of glucocorticoid re-
ceptor in lymphocyte subsets, with higher serum 
cortisol concentration than healthy subjects. Ma-
jority of other studies did not take into account 
the time passed since the trauma and their sam-
ples mainly included Vietnam veterans (15) or 
Holocaust survivors (16), who had greater time 
gap since the traumatic experience than Croatian 
war veterans.
Considering the strong discrepancies in the 
results published to date, we performed a cross-
sectional study to evaluate the correlation be-
tween PTSD in Croatian combat war veterans 
on and the percentages of circulating lymphocyte 
subsets, natural killer cell cytotoxicity as a mea-
sure of immune function, and the serum cortisol 
concentration with lymphocyte glucocorticoid 
receptor expression as components of hypotha-
lamic-pituitary-adrenal axis. The emphasis was 
put on the relationship between the assessed pa-




PTSD patients were Croatian combat veterans, 
all men (Table 1), recruited from the outpatient 
PTSD program at Vrapče Psychiatric Hospital 
during the year 2004. Before entering the study, 
all patients met the International Classifica-
tion of Disorders (ICD)-10 (17) PTSD criteria, 
the official classification in Croatian psychiatric 
practice. For the purposes of this study, the diag-
nosis of PTSD, as well as the specificities of clini-
cal picture (frequency and intensity of all and se-
lected PTSD symptoms during the period of one 
month prior to rating), were determined by using 
the Diagnostic and Statistical Manual of Mental 
Disorders (DSM)-IV (18) based Clinician-Ad-
ministered PTSD Scale (CAPS) (19) and all 38 
patients met the criteria for chronic PTSD. Only 
the patients without psychiatric premorbidity or 
comorbidity, including major depression, were 
selected for the purpose of this study. Each pa-
tient had at least one “reexperiencing symptom” 
within the criterion B, at least 3 “avoidance and 
numbing symptoms” within the criterion C, and 
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at least 2 “hyperarousal symptoms” within the 
criterion D. No patients had subsyndromal form 
of PTSD. In relation to DSM-IV A (traumatic 
event) criterion, each patient witnessed another 
person’s death and experienced a threat to their 
physical integrity and/or wounding. On the basis 
of intrusive thoughts content, the focal traumat-
ic experience was identified and the time passed 
until assessment was recorded. The PTSD group 
was relatively homogenous related to the severity 
of the illness. The average severity of PTSD was 
qualified as moderate (median = 4; interquartile 
range = 4 to 5), according to the Clinical Global 
Impression Severity (CGI-S) scale (20). Control 
subjects were sex-matched healthy civilians, hos-
pital and laboratory personnel with no combat 
experience.
Prior to blood drawing, healthy civilians were 
examined by an experienced physician and their 
histories were recorded. All controls had negative 
history of psychiatric disorders.
None of the participants used any psycho-
tropic medication, drug, or reported alcohol 
abuse for at least one month, and did not suffer 
from any infectious, allergic, or endocrine disor-
der. They had no symptoms or signs of acute or 
chronic physical illness.
The study was approved by the Ethic Com-
mittee of the hospital and written informed con-
sent was obtained from all subjects.
Blood samples
Heparinized and unheparinized blood samples 
(10 mL each) were collected by venipuncture be-
tween 8 and 9 am in Vacutainer tubes (Becton 
Dickinson Vacutainer System Europe, Grenoble, 
France). A part of the whole heparinized blood 
(50 μL per tube) was used for the lymphocyte im-
munophenotyping and glucocorticoid receptor 
expression determination by flow cytometry. Pe-
ripheral blood mononuclear cells (PBMC) were 
separated by centrifugation on Ficoll-Hypaque 
(Pharmacia AB, Uppsala, Sweden) density gra-
dient and used for natural killer cell cytotoxici-
ty determination. The sera for determination of 
cortisol concentration were stored at -80°C.
Immunophenotyping and intracellular 
glucocorticoid receptor determination
Lymphocyte counts were determined by flow 
cytometry, using Flow-CountTM Fluorospheres 
(Coulter Corporation, Miami, FL, USA) accord-
ing to the manufacturer’s protocol. Flow cyto-
metric, three-color staining method was used for 
the simultaneous labeling of surface lymphocyte 
markers and intracellular lymphocyte glucocor-
ticoid receptor expression. The method was pre-
viously described in detail (14). Briefly, surface 
staining was achieved by phycoerytrin (PE) con-
jugated anti-CD3, anti-CD16,56, anti-IgG2a, 
and peridinin chlorophyll protein (PerCP) con-
jugated anti-CD4, anti-CD8, anti-CD20, anti-
IgG1 monoclonal antibodies (MoAb) (Becton 
Dickinson, Heidelberg, Germany), 5 μL per 50 
μL of whole blood each. After incubation in the 
dark for 15 minutes, cells were washed and fixed, 
followed by erythrocytes lysis. The cells were 










Age (mean±SD) 44.3 ± 9.4 39.0 ± 8.4  0.028
Tobacco use 24 13  0.330
Marital status:  0.443
 married 21 12
 unmarried/divorced/widower 17 12
Lives with the family‡ 32 22  0.329
Education:  0.006
 elementary school  5  0
 high school 28 13
 university education  5 11
Work status:  0.012
 employed 22 21
 retired 11  0
 unemployed  5  3
CAPS (mean±SD):
 reexperiencing 16.5 ± 2.2  0
 avoidance/numbing 26.1 ± 3.1  0
 hyperarousal 15.7 ± 3.3 0.5 ± 1.1
 total 58.3 ± 7.0 0.5 ± 1.1 <0.001
Delayed§ 20/38
Years from trauma 
 (median, range)
12 (8-13)
*Abbreviations: PTSD – posttraumatic stress disorder; SD – standard deviation; CAPS 
– Clinician-administered PTSD Scale.
†Two-sided values obtained using Fisher exact tests for 2×2 tables, Pearson χ2 tests 
for 3×2 tables, and t tests; statistically significant if P<0.05.
‡Lives with the family.
§The onset of symptoms after the first six months of traumatic incident.
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then washed in the permeabilization buffer, con-
taining predetermined optimal concentration of 
fluorescein isothiocyanate (FITC) conjugated 
anti-glucocorticoid receptor MoAb (21) or 5 μL 
of isotype control, left for 20 minutes in the dark, 
washed with permeabilization buffer again, and 
resuspended in 500 μL of fixation buffer. Pre-
pared samples were run on FACSCalibur flow 
cytometer and analyzed by CELLQuest software 
(Becton Dickinson, Heidelberg, Germany). At 
least 5000 events in the light-scatter lymphocyte 
gate were acquired and the percentages of sur-
face marker positive cells were determined in PE 
vs PerCP dot plots. The relative quantity of lym-
phocyte glucocorticoid receptor (mean glucocor-
ticoid receptor fluorescence), expressed as mean 
fluorescence intensity, was calculated as the dif-
ference between mean values of glucocorticoid 
receptor and isotype control (Figure 1). The in-
strument calibration was performed on a daily 
basis.
Natural killer cell cytotoxicity
The in vitro natural killer cell cytotoxicity toward 
51Cr-labeled K562 target cells (185 MBq/mL, 
Amersham, Little Chalfont, UK) was performed 
according to the previously described technique 
(22). We represented natural killer cell activity as 
the mean percentage of lysis across three effector-
target cell ratios (25:1, 50:1, 100:1) (Table 2). 
Lytic units were not calculated because not all of 
our data fitted the assumptions required for lytic 
unit transformation. To avoid missing data and 
minimize the number of comparisons and conse-
quent type I error, only the mean percentage of 
lysis was included in the overall analyses.
Serum cortisol determination
Serum cortisol concentration was determined by 
the radioimmunoassay kit CORT-CT2 (Scher-
ing S.A. Cis bio international, Gif-sur-Yvette, 
France). All samples were analyzed in duplicates 
following manufacturer’s protocol. The sensitiv-
ity of the assay was 0.17 μg/100 mL, and the in-
tra-assay and inter-assay coefficients of variation 
were less than 6% and 8%, respectively.
Statistical analysis
Categorical data were analyzed using Fisher ex-
act or Pearson χ2 tests. Since not all continuous 
variables were normally distributed, as confirmed 
with Shapiro-Wilk W test, transformations were 
applied to meet parametric tests assumptions of 
normality and homogeneity of variance (assessed 
Figure 1. Representative flow cytometric analysis of glucocorticoid receptor expression in lymphocytes of the patient with posttraumatic stress 
disorder (PTSD). Lymphocytes were gated on light scatter dot plot (A), and the relative quantity of glucocorticoid receptor was calculated as the dif-
ference between mean fluorescence intensity of glucocorticoid receptor and isotype control (B). Overlaying histograms show that the glucocorticoid 
receptor expression is higher in PTSD patient. SSC-H – side scatter-hight; FSC-H – forward scatter-hight; GCR – glucocorticoid receptor; FITC 
– fluorescein isothiocyanate; full line – patient with posttraumatic stress disorder, dashed line – healthy volunteer.
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by Levene test). The group differences were test-
ed with analysis of covariance (ANCOVA), us-
ing age as covariate, and two-tailed t tests. Data 
could not be modeled to meet multivariate test 
assumptions, leaving the greater possibility of 
type I error because of the multiple comparisons 
performed. Therefore, we used the false discov-
ery rate method (23) for 9 group comparisons 
and 15 planned correlations. Partial correlations 
controlling for age and smoking in both groups, 
including “delayed” factor only in PTSD group, 
were performed. Correlations with the number 
of years since the trauma were examined using 
nonparametric Spearman rank order correlations 
because this variable could not be normalized. All 
statistical analyses were performed with Statisti-
ca, version 6 (StatSoft, Inc., Tulsa, OK, USA).
Results
Group comparisons
Groups were not matched by age, education, and 
work status. PTSD patients were slightly old-
er, less educated, and substantial proportion of 
them was retired (Table 1). The age difference 
was considered as possible confounding factor, 
but ANCOVA, using age as a covariate, showed 
no significant effect of age on the investigated 
variables (Table 2). Results based on raw P value 
from t test indicated higher lymphocyte count in 
PTSD patients and the calculated power yielded 
80% for group sample sizes of 38 and 24. Calcu-
lation for two-sided two-sample t test was based 
on the observed difference of 477.4/μL, with 
group standard deviations of 678.0 and 637.0, 
and with significance level (α) set to 0.05. How-
ever, with α set to 0.006, as indicated by false dis-
covery rate threshold value (d), calculated power 
yielded only 56%, with a sample size of 49 par-
ticipants per group needed to achieve the pow-
er of 80%. No other measured parameter signifi-
cantly different between the PTSD patients and 
healthy volunteers (Table 2).
Correlational analyses
No biological parameter significantly corre-
lated with total CAPS scores, but the number 
of years after trauma positively correlated with 
lymphocyte glucocorticoid receptor expression, 
as indicated by the raw P value (Figure 2). Posi-
tive correlation was also found between lympho-
cyte glucocorticoid receptor expression and se-
rum cortisol concentration in the PTSD patients 
(r = 0.46, P = 0.006, d = 0.003) and healthy vol-
unteers (r = 0.46, P = 0.035, d = 0.010). How-
ever, false discovery rate analysis indicated type I 
error since all P values exceeded corresponding d 
Table 2. Comparison of the immune and endocrine parameters between PTSD patients and healthy volunteers*
Findings in participants Statistics
Variable† PTSD patients (n = 38) healthy volunteers (n = 24) t P d‡
Lymphocytes (count/μL) 2294.7 (2077.8-2511.5) 1817.2 (1544.3-2090.1)  2.763 0.007 0.006
T cells (%)   70.7 (67.5-73.8)   67.9 (63.6-71.9)  0.812 0.419 0.028
Helper T cells (%)   44.8 (42.0-47.5)   42.2 (38.7-45.6)  1.023 0.310 0.017
Cytotoxic T cells (%)   22.8 (20.3-25.6)   20.8 (17.9-24.1)  0.768 0.444 0.039
B cells (%)   11.2 (9.8-12.8)   11.5 (9.7-13.5) -0.237 0.813 0.050
Natural killer cells (%)   16.2 (13.7-18.8)   17.9 (14.7-21.5) -0.276 0.783 0.044
Natural killer cell cytotoxicity (mean)§   45.5 (39.2-51.7)   47.4 (39.4-55.4) -0.778 0.439 0.033
 (25:1)   31.6 (25.5-37.8)   35.0 (27.5-42.5) -0.711 0.480
 (50:1)   46.5 (40.1-52.4)   49.5 (41.7-51.4) -0.629 0.532
 (100:1)   56.5 (50.8-62.2)   59.6 (52.2-67.1) -0.684 0.497
Lymphocyte glucocorticoid receptor (m.f.i.)   42.5 (38.5-46.6)   39.2 (34.5-44.3)  0.856 0.394 0.022
Cortisol (μg/100 mL)   13.7 (11.1-16.5)   12.0 (9.1-15.4)  1.140 0.258 0.011
*Abbreviations: PTSD – posttraumatic stress disorder; m.f.i. – mean fluorescence intensity.
†Values are means or backtransformed means with 95% confidence intervals in the parentheses. To meet t test assumptions variables were transformed as follows: square for T cells 
(CD3+), logarithm for cytotoxic T cells (CD3+CD8+), square root for B cells (CD20+), natural killer cells (CD56+CD16+), glucocorticoid receptor, and cortisol.
‡Threshold value calculated using the false discovery rate method. If the P value exceeds corresponding d, performed test is not statistically significant at 0.05 level.
§Percentage of lysis represented as the mean of three effector:target cell ratios (25:1, 50:1, 100:1), separate effector:target cell ratios were not included in the calculation of d values.
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values (Table 2). The other planned correlations 
of cortisol concentration, lymphocyte count, and 
natural killer cell cytotoxicity with the number 
of years from trauma, were not statistically signif-
icant.
Discussion
Our study showed increased lymphocyte count 
in PTSD patients and positive correlation of the 
lymphocyte glucocorticoid receptor expression 
with the time passed since traumatic experience. 
The effect of PTSD on the peripheral blood lym-
phocyte subsets, the immune cell function mea-
sured by natural killer cell cytotoxicity, and the 
components of hypothalamic-pituitary-adrenal 
axis was not observed.
Generally, few studies on the immunity in 
PTSD have been published to date and even 
fewer addressed well-characterized fully devel-
oped PTSD according to the DSM-IV criteria. 
Our study could not confirm either the previous 
findings of higher peripheral blood percentages 
of helper T cells (CD4) and natural killer cells 
(CD16,56) in Croatian PTSD patients (24), 
or higher percentages of T cells (CD3), CD4, 
and cytotoxic T cells (CD8) in Vietnam veter-
ans (11). However, other studies also reported 
the lack of differences in the peripheral blood 
lymphocyte phenotype in combat-related (12), 
or childhood sexual abuse-related (10) chronic 
PTSD. Recently, Boscarino et al (3) showed that 
Vietnam veterans with PTSD had higher lym-
phocyte counts, consistent with the higher prev-
alence of autoimmune diseases. We noticed that 
PTSD patients had higher lymphocyte counts in 
this group, as well as in other examined PTSD 
groups (our unpublished data), although this rise 
could not be contributed to any particular lym-
phocyte subpopulation, as seen from the lack of 
difference between percentages of subpopula-
tions. However, observed difference in lympho-
cyte count must be interpreted with caution 
because of the possibility of type I error, as indi-
cated by false discovery rate analysis. Our future 
study will address the same question by examin-
ing a larger group of patients (minimally 49 per 
group, as shown by the sample size analysis).
Research on the immune function in PTSD 
showed generally an increased delayed-type hy-
persensitivity (3,25), higher percentage of perfo-
rin positive natural killer cells (24), and inconclu-
sive natural killer cell cytotoxicity measurements 
(12,26,27). According to the results from chron-
ic stress studies of decreased natural killer cell cy-
totoxicity (28), the same would be expected in 
chronic PTSD. Nevertheless, it was shown that 
Croatian professional soldiers released from con-
centration camp had higher natural killer cell cy-
totoxicity (29). Moreover, our preliminary results 
of a six years follow-up indicate that natural kill-
er cell cytotoxicity declines over time in chronic 
PTSD, after the initial increase within eight years 
from the trauma, compared with healthy individ-
uals (30). In this study, we were not able to show 
the group difference in natural killer cell cyto-
toxicity, as well as expected negative correlation 
with the time passed since the trauma. Prospec-
Figure 2. Correlation between the glucocorticoid receptor (GCR) ex-
pression in lymphocytes and number of years passed since the trauma. 
Spearman rank order correlation controlled by the false discovery rate 
at α = 0.05 for total number of 15 correlations performed in this study: 
rs = 0.43, P = 0.008, d = 0.007; m.f.i. – mean fluorescence intensity.
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tive studies are needed to elucidate the dynamics 
of the immune function in chronic PTSD.
In contrast to immunological studies, exten-
sive research has been done regarding the com-
ponents of hypothalamic-pituitary-adrenal axis 
in PTSD (5). In fact, low cortisol level with en-
hanced negative feedback sensitivity to cortisol, 
ie, higher number of glucocorticoid receptors, is 
considered to be a distinctive biological feature 
of PTSD that separates this disorder from other 
psychiatric conditions such as depression (31). 
Simultaneous determination of cortisol and its 
receptor enables better characterization of the 
hypothalamic-pituitary-adrenal axis than cortisol 
alone (32). Using this approach, we found that 
Croatian combat veterans had higher cortisol 
concentration with lower lymphocyte glucocor-
ticoid receptor expression (14). This finding was 
attributed to the limited duration of PTSD com-
pared with other studies, and thus shorter dura-
tion of the stress response with preserved nega-
tive feedback by higher cortisol levels. During the 
repeated activation of stress response, as seen in 
PTSD, the stress system re-establishes stability 
at a higher set point by the process called allosta-
sis that, over time, becomes a burden for the liv-
ing system (allostatic load) (33). Thus, we expect 
that PTSD patients will adopt distinctive hypo-
thalamic-pituitary-adrenal axis profile if the dis-
order persists. Present study investigated a group 
of PTSD patients with longer duration of the 
disorder (8 to 13 in this study vs 6 to 8 years in 
the previous study), so the lack of difference be-
tween the groups was not surprising. Moreover, 
Yehuda et al (34) showed a positive correlation 
between the amount of cortisol suppression after 
a low dose of dexamethasone (indirect glucocor-
ticoid receptor sensitivity measure) and the num-
ber of years passed since the traumatic event. The 
hypothesis that the duration of allostatic load is 
the key factor in the modulation of hypothalam-
ic-pituitary-adrenal axis activity is further sup-
ported by the positive correlation between lym-
phocyte glucocorticoid receptor expression and 
the number of years from the trauma found in 
this study (Figure 1). Preliminary results from 
our ongoing follow-up study, which show signif-
icant decrease of the glucocorticoid receptor ex-
pression in PTSD patients after six years follow 
up period, also support this hypothesis (30).
Another positive correlation between cortisol 
concentration and lymphocyte glucocorticoid re-
ceptor observed in this study suggests that factors 
other than endogenous glucocorticoids are in-
volved in the mutual modulation of glucocorti-
coid receptor expression and cortisol secretion. 
A possible candidate is interleukin (IL)-6, which 
directly stimulates production of glucocorticoids 
(35) and also up-regulates glucocorticoid recep-
tor and expression of glucocorticoid receptor 
mRNA in peripheral blood mononuclear cells 
(36). Although some studies reported increased 
IL-6 in cerebrospinal fluid (37) and sera (38) of 
PTSD patients, our future studies will further in-
vestigate the proposed relationship.
We should also point out the limitations of 
this study. The age difference could have con-
founded the results because aging is associated 
with the immunological changes that resemble 
those following chronic stress (39). Since this 
difference was very small and statistically con-
trolled for by ANCOVA, it should have not in-
terfered with the results. Another possible lim-
itation is that 9 healthy controls were chosen 
from psychiatry hospital personnel (psychiatrists 
and technicians) who are believed to experience 
higher amount of stress than laboratory person-
nel or other healthy civilians not working in the 
hospital. Careful examination of the biological 
data from these individuals did not show any de-
viations from their counterparts in the control 
group. Although the examined group of patients 
was well-defined, relatively homogeneous, and 
without psychiatric comorobidities, depressive 
symptoms were not controlled for, neither in the 
PTSD nor in the control group.
Cross-sectional research of PTSD is connect-
ed with many obstacles, and inconsistency of the 
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results in literature may be due to differences in 
gender, age, stressor type, diagnostic instrument 
chosen, and timing of the assessment in relation 
to the trauma onset. Moreover, biological chang-
es in PTSD are very small and large sample sizes 
are needed to obtain enough statistical power to 
confirm them. Because of the lack of power, re-
sults from this study are more indicative than 
conclusive. More controlled laboratory challeng-
es could reveal group differences in biological pa-
rameters in relation to acute individualized trau-
matic stimuli (40) and long term prospective 
studies (41) could confirm the dynamics of en-
docrine and immune parameters in PTSD impli-
cated in this study.
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